Characteristics of Mpox Vaccine Recipients Among a Sample of Men Who Have Sex With Men With Presumed Exposure to Mpox

Abstract

Mpox vaccination is recommended for persons exposed to or at risk for mpox. Approximately 25% of an online sample of men who have sex with men (MSM) with presumed mpox exposure were vaccinated (≥1 dose). Vaccination was higher among younger MSM, MSM concerned about mpox, or MSM reporting sexual risk behaviors. Incorporating mpox vaccination into routine sexual health care and increasing 2-dose vaccination uptake is essential to preventing mpox acquisition, improving MSM sexual health, and averting future mpox outbreaks.

Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis

“…Older age has been reported to be associated with higher intention to accept 51 , 89 , 97 , lower intention to accept 65 , 93 , 94 , 98 , and higher hesitancy 95 . Younger age was associated with higher uptake 47 , 53 , 96…”

“…The prevalence of intention to vaccinate was not reported by nine studies 39 – 47 , uptake rates were reported by seventeen studies 39 – 42 , 44 – 56 , rates of uptake among those who indicated acceptance were reported by eight studies 48 , 50 – 56 , and mpox acceptance rate was reported by all included studies. Overall, all six WHO regions were represented, with AFR (Algeria, Ghana, Nigeria) having four studies 39 , 57 – 59 , AMR having eleven studies 40 , 42 , 45 , 47 , 54 , 55 , 60 – 64 , EMR (Iraq, Pakistan, Saudi Arabia) having eight studies 65 – 72 , EUR (all WHO European member countries) having seventeen studies 41 , 44 , 48 , 51 , 52 , 56 , 73 – 83 , SEAR (Indonesia, Bangladesh, Japan) three studies 84 – 86 , and the WPR (China, Malaysia, Australia) having twelve studies 49 , 50 , 53 , 87 – 95 . The acceptance rate among PLHIV was reported by fourteen studies 41 , 47 , 49 , 50 , 52 – 54 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , the rate of intention to be vaccinated was reported by nine 50 , 52 , 63 , 74 , 78 , 79 , 87 ,...…”

“…Overall, all six WHO regions were represented, with AFR (Algeria, Ghana, Nigeria) having four studies 39 , 57 – 59 , AMR having eleven studies 40 , 42 , 45 , 47 , 54 , 55 , 60 – 64 , EMR (Iraq, Pakistan, Saudi Arabia) having eight studies 65 – 72 , EUR (all WHO European member countries) having seventeen studies 41 , 44 , 48 , 51 , 52 , 56 , 73 – 83 , SEAR (Indonesia, Bangladesh, Japan) three studies 84 – 86 , and the WPR (China, Malaysia, Australia) having twelve studies 49 , 50 , 53 , 87 – 95 . The acceptance rate among PLHIV was reported by fourteen studies 41 , 47 , 49 , 50 , 52 – 54 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , the rate of intention to be vaccinated was reported by nine 50 , 52 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , while uptake rate was reported by eight studies 41 , 47 , 49 , 50 , 52 – 54 , 96 . Among the LGBTQI+ community, the acceptance rate was reported by twenty-one studies 42 , 45 , …”

“…The acceptance rate among PLHIV was reported by fourteen studies 41 , 47 , 49 , 50 , 52 – 54 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , the rate of intention to be vaccinated was reported by nine 50 , 52 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , while uptake rate was reported by eight studies 41 , 47 , 49 , 50 , 52 – 54 , 96 . Among the LGBTQI+ community, the acceptance rate was reported by twenty-one studies 42 , 45 , 47 , 49 – 53 , 55 , 56 , 62 , 63 , 74 , 78 – 80 , 87 , 89 , 91 , 93 , 95 , rate of intention to vaccinate was reported by seventeen stuides 50 – 53 , 55 , 56 , 62 , 63 , 74 , 78 – 80 , 87 , 89 , 91 , 93 , 95 , while rate of uptake was reported by studies 42 , 45 , 47 , 49 ...…”

“…Apart from these two multiregional studies. All other studies were single-country studies, with US having the highest number of studies (nine) 40 , 42 , 43 , 45 , 47 , 54 , 60 , 61 , 96 followed by the China (eight) 49 – 51 , 65 , 67 , 75 , 89 and Saudi Arabia (four) 65 – 67 , 69 . In all, a total of 87 countries were represented in this review.…”